Post-test

Prevalence and Management of Benign Prostatic Hyperplasia (BPH)

Post Test

1.

Enlarged prostate is the 4th most diagnosed disease in men over 50.
True
False

2.

There is a relationship between prostate volume and serum PSA in patients with BPH.
True
False

3.

Irritative Lower Urinary Tract Symptoms (LUTS) include
a. Nocturia
b. Urgency
c. Frequency
d. Urge Incontinence
e. All of the above

4.

All studies agree the prevalence of histologic BPH increases with age.
True
False

5.

The American Urological Association Symptom Index (AUA-SI) is used to help diagnosis BPH.
True
False

6.

In addition to age of 50 and older, risk factors for BPH progression include:
a.PSA greater or equal to 1.5
b. AUA-SI score of greater than 7
c. Prostate enlarged to equal or more than 30 to 40 ml.
d. All of the above

7.

BPH treatment options include
a. Laser surgery
b. Major surgery such as prostatectomy
c. Pharmacologic therapy
d. Active surveillance
e. Minimally invasive therapy
f. All of the above

8

American Urological Association Guidelines state all a-adrenergic blockers are appropriate treatment for patients with LUTS secondary to BPH.
True
False

9

In some patients, treating with a combination of a-adrenergic blocker and 5ARI is most effective in:
a. Improving maximum urinary flow rate
b. Reducing risk of clinical progression
c. Improving AUA symptom score
d. All of the above

10

Thermotherapy is minimally invasive and includes transurethral needle ablation, transurethral microwave and interstitial laser coagulation.
True
False

11

In thermotherapy, tissue necrosis/nerve damage leads to improved voiding symptoms
True
False

12

AUA Guidelines on BPH management include:
a. Discussion of therapeutic options
b. Watchful waiting
c. Diagnostic Tests
d. Minimally Invasive Therapies
e. Medical Therapy
f. Surgical Therapies
g. All of the above

Activity Evaluation

Please rate this activity on the following scale:
4 - Excellent 3 - Good 2 - Fair 1 - Poor

Due to the content of this activity, I will change my practice patterns by:

	Reviewing current plan guideline for the screening of BPH
	Providing appropriate education to our providers on the AUA Guidelines
	Identifying patients to prevent disease progression
	My practice patterns will not change

Continuing education implies quality improvement in behavior. As part of our quality improvement process, NAMCP/AAMCN will contact you 6 months from your post test submission to monitor change.